TBA1C_HUMAN - dbPTM
TBA1C_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TBA1C_HUMAN
UniProt AC Q9BQE3
Protein Name Tubulin alpha-1C chain
Gene Name TUBA1C
Organism Homo sapiens (Human).
Sequence Length 449
Subcellular Localization Cytoplasm, cytoskeleton.
Protein Description Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain..
Protein Sequence MRECISIHVGQAGVQIGNACWELYCLEHGIQPDGQMPSDKTIGGGDDSFNTFFSETGAGKHVPRAVFVDLEPTVIDEVRTGTYRQLFHPEQLITGKEDAANNYARGHYTIGKEIIDLVLDRIRKLADQCTGLQGFLVFHSFGGGTGSGFTSLLMERLSVDYGKKSKLEFSIYPAPQVSTAVVEPYNSILTTHTTLEHSDCAFMVDNEAIYDICRRNLDIERPTYTNLNRLISQIVSSITASLRFDGALNVDLTEFQTNLVPYPRIHFPLATYAPVISAEKAYHEQLTVAEITNACFEPANQMVKCDPRHGKYMACCLLYRGDVVPKDVNAAIATIKTKRTIQFVDWCPTGFKVGINYQPPTVVPGGDLAKVQRAVCMLSNTTAVAEAWARLDHKFDLMYAKRAFVHWYVGEGMEEGEFSEAREDMAALEKDYEEVGADSADGEDEGEEY
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
6O-linked_Glycosylation--MRECISIHVGQAG
--CCCEEEEEECCHH
20.5028510447
6Phosphorylation--MRECISIHVGQAG
--CCCEEEEEECCHH
20.50-
24PhosphorylationGNACWELYCLEHGIQ
CHHHHHCHHHHCCCC
5.40-
38O-linked_GlycosylationQPDGQMPSDKTIGGG
CCCCCCCCCCCCCCC
46.5328510447
38PhosphorylationQPDGQMPSDKTIGGG
CCCCCCCCCCCCCCC
46.5326074081
40AcetylationDGQMPSDKTIGGGDD
CCCCCCCCCCCCCCC
46.5124906155
40UbiquitinationDGQMPSDKTIGGGDD
CCCCCCCCCCCCCCC
46.5124906155
41O-linked_GlycosylationGQMPSDKTIGGGDDS
CCCCCCCCCCCCCCC
29.8228510447
41PhosphorylationGQMPSDKTIGGGDDS
CCCCCCCCCCCCCCC
29.8225463755
48PhosphorylationTIGGGDDSFNTFFSE
CCCCCCCCHHHCCCC
25.7419664994
51PhosphorylationGGDDSFNTFFSETGA
CCCCCHHHCCCCCCC
24.8529255136
54PhosphorylationDSFNTFFSETGAGKH
CCHHHCCCCCCCCCC
30.0225159151
56O-linked_GlycosylationFNTFFSETGAGKHVP
HHHCCCCCCCCCCCC
31.0028510447
56PhosphorylationFNTFFSETGAGKHVP
HHHCCCCCCCCCCCC
31.0023927012
60SumoylationFSETGAGKHVPRAVF
CCCCCCCCCCCEEEE
40.68-
60AcetylationFSETGAGKHVPRAVF
CCCCCCCCCCCEEEE
40.6819811241
60SumoylationFSETGAGKHVPRAVF
CCCCCCCCCCCEEEE
40.6819608861
60UbiquitinationFSETGAGKHVPRAVF
CCCCCCCCCCCEEEE
40.6820639865
73PhosphorylationVFVDLEPTVIDEVRT
EEECCCCEEEHHCCC
22.2530108239
80O-linked_GlycosylationTVIDEVRTGTYRQLF
EEEHHCCCCCCHHCC
38.7728510447
80PhosphorylationTVIDEVRTGTYRQLF
EEEHHCCCCCCHHCC
38.7728857561
82PhosphorylationIDEVRTGTYRQLFHP
EHHCCCCCCHHCCCH
18.2128857561
83PhosphorylationDEVRTGTYRQLFHPE
HHCCCCCCHHCCCHH
9.5628857561
94O-linked_GlycosylationFHPEQLITGKEDAAN
CCHHHHCCCCHHHHH
51.2828510447
94PhosphorylationFHPEQLITGKEDAAN
CCHHHHCCCCHHHHH
51.2828152594
96SumoylationPEQLITGKEDAANNY
HHHHCCCCHHHHHHC
43.71-
96AcetylationPEQLITGKEDAANNY
HHHHCCCCHHHHHHC
43.7130584151
96SumoylationPEQLITGKEDAANNY
HHHHCCCCHHHHHHC
43.71-
96UbiquitinationPEQLITGKEDAANNY
HHHHCCCCHHHHHHC
43.7120639865
103PhosphorylationKEDAANNYARGHYTI
CHHHHHHCCCCCCCC
9.4827155012
108PhosphorylationNNYARGHYTIGKEII
HHCCCCCCCCCHHHH
11.6825884760
109O-linked_GlycosylationNYARGHYTIGKEIID
HCCCCCCCCCHHHHH
19.9928510447
109PhosphorylationNYARGHYTIGKEIID
HCCCCCCCCCHHHHH
19.9928796482
112SumoylationRGHYTIGKEIIDLVL
CCCCCCCHHHHHHHH
41.72-
112AcetylationRGHYTIGKEIIDLVL
CCCCCCCHHHHHHHH
41.7219608861
112SumoylationRGHYTIGKEIIDLVL
CCCCCCCHHHHHHHH
41.7219608861
112UbiquitinationRGHYTIGKEIIDLVL
CCCCCCCHHHHHHHH
41.7219608861
124AcetylationLVLDRIRKLADQCTG
HHHHHHHHHHHHCCC
45.73156239
124UbiquitinationLVLDRIRKLADQCTG
HHHHHHHHHHHHCCC
45.7321906983
145O-linked_GlycosylationFHSFGGGTGSGFTSL
EEECCCCCCCCHHHH
31.3028510447
147O-linked_GlycosylationSFGGGTGSGFTSLLM
ECCCCCCCCHHHHHH
30.4828510447
151PhosphorylationGTGSGFTSLLMERLS
CCCCCHHHHHHHHHC
19.76-
158PhosphorylationSLLMERLSVDYGKKS
HHHHHHHCCCCCCCC
21.1128355574
161PhosphorylationMERLSVDYGKKSKLE
HHHHCCCCCCCCCEE
28.7923911959
163AcetylationRLSVDYGKKSKLEFS
HHCCCCCCCCCEEEE
47.87129755
163MethylationRLSVDYGKKSKLEFS
HHCCCCCCCCCEEEE
47.87129755
163UbiquitinationRLSVDYGKKSKLEFS
HHCCCCCCCCCEEEE
47.8721890473
164UbiquitinationLSVDYGKKSKLEFSI
HCCCCCCCCCEEEEE
48.7521906983
165PhosphorylationSVDYGKKSKLEFSIY
CCCCCCCCCEEEEEE
46.0622817900
166UbiquitinationVDYGKKSKLEFSIYP
CCCCCCCCEEEEEEE
62.00-
170PhosphorylationKKSKLEFSIYPAPQV
CCCCEEEEEEECCCC
16.3123663014
172PhosphorylationSKLEFSIYPAPQVST
CCEEEEEEECCCCCE
7.6723663014
178PhosphorylationIYPAPQVSTAVVEPY
EEECCCCCEEEEECC
12.8523663014
179PhosphorylationYPAPQVSTAVVEPYN
EECCCCCEEEEECCC
25.3123663014
185PhosphorylationSTAVVEPYNSILTTH
CEEEEECCCCCCCCC
14.1823663014
187PhosphorylationAVVEPYNSILTTHTT
EEEECCCCCCCCCCC
17.0923663014
190PhosphorylationEPYNSILTTHTTLEH
ECCCCCCCCCCCCCC
18.1823663014
191PhosphorylationPYNSILTTHTTLEHS
CCCCCCCCCCCCCCC
17.4923663014
193PhosphorylationNSILTTHTTLEHSDC
CCCCCCCCCCCCCCE
30.8623663014
194PhosphorylationSILTTHTTLEHSDCA
CCCCCCCCCCCCCEE
23.6523663014
198PhosphorylationTHTTLEHSDCAFMVD
CCCCCCCCCEEEEEC
25.6326356563
210PhosphorylationMVDNEAIYDICRRNL
EECHHHHHHHHHCCC
13.3025884760
223PhosphorylationNLDIERPTYTNLNRL
CCCCCCCCHHCHHHH
49.5528796482
224PhosphorylationLDIERPTYTNLNRLI
CCCCCCCHHCHHHHH
9.0519605366
225O-linked_GlycosylationDIERPTYTNLNRLIS
CCCCCCHHCHHHHHH
35.3928510447
225PhosphorylationDIERPTYTNLNRLIS
CCCCCCHHCHHHHHH
35.3928555341
232PhosphorylationTNLNRLISQIVSSIT
HCHHHHHHHHHHHHH
20.6021712546
236PhosphorylationRLISQIVSSITASLR
HHHHHHHHHHHHHCC
20.0423403867
237PhosphorylationLISQIVSSITASLRF
HHHHHHHHHHHHCCC
17.0523403867
239PhosphorylationSQIVSSITASLRFDG
HHHHHHHHHHCCCCC
16.4923403867
241PhosphorylationIVSSITASLRFDGAL
HHHHHHHHCCCCCCC
16.0723403867
253PhosphorylationGALNVDLTEFQTNLV
CCCCCCCCEEECCCC
30.2321712546
257O-linked_GlycosylationVDLTEFQTNLVPYPR
CCCCEEECCCCCCCC
35.5228510447
257PhosphorylationVDLTEFQTNLVPYPR
CCCCEEECCCCCCCC
35.5221712546
262PhosphorylationFQTNLVPYPRIHFPL
EECCCCCCCCCCCCC
9.5422817901
271O-linked_GlycosylationRIHFPLATYAPVISA
CCCCCCCCCCCCCCH
28.0928510447
271PhosphorylationRIHFPLATYAPVISA
CCCCCCCCCCCCCCH
28.0921945579
272PhosphorylationIHFPLATYAPVISAE
CCCCCCCCCCCCCHH
11.8721945579
277O-linked_GlycosylationATYAPVISAEKAYHE
CCCCCCCCHHHHHHH
30.5228510447
277PhosphorylationATYAPVISAEKAYHE
CCCCCCCCHHHHHHH
30.5221945579
280AcetylationAPVISAEKAYHEQLT
CCCCCHHHHHHHCCC
54.7088231
280UbiquitinationAPVISAEKAYHEQLT
CCCCCHHHHHHHCCC
54.70-
282Nitrated tyrosineVISAEKAYHEQLTVA
CCCHHHHHHHCCCHH
19.56-
282NitrationVISAEKAYHEQLTVA
CCCHHHHHHHCCCHH
19.56-
282PhosphorylationVISAEKAYHEQLTVA
CCCHHHHHHHCCCHH
19.5622817900
287PhosphorylationKAYHEQLTVAEITNA
HHHHHCCCHHHHHHH
19.84-
292PhosphorylationQLTVAEITNACFEPA
CCCHHHHHHHHCCCH
14.3126126808
295GlutathionylationVAEITNACFEPANQM
HHHHHHHHCCCHHHC
4.2722555962
302SulfoxidationCFEPANQMVKCDPRH
HCCCHHHCCCCCCCC
2.8930846556
304UbiquitinationEPANQMVKCDPRHGK
CCHHHCCCCCCCCCC
27.8121906983
311AcetylationKCDPRHGKYMACCLL
CCCCCCCCEEEEHHH
26.23129747
311UbiquitinationKCDPRHGKYMACCLL
CCCCCCCCEEEEHHH
26.2321890473
312PhosphorylationCDPRHGKYMACCLLY
CCCCCCCEEEEHHHC
8.4428152594
315GlutathionylationRHGKYMACCLLYRGD
CCCCEEEEHHHCCCC
0.6722555962
319PhosphorylationYMACCLLYRGDVVPK
EEEEHHHCCCCCCCC
10.2923917254
326SumoylationYRGDVVPKDVNAAIA
CCCCCCCCCCHHHHH
63.80-
326AcetylationYRGDVVPKDVNAAIA
CCCCCCCCCCHHHHH
63.8022632557
326SumoylationYRGDVVPKDVNAAIA
CCCCCCCCCCHHHHH
63.80-
326UbiquitinationYRGDVVPKDVNAAIA
CCCCCCCCCCHHHHH
63.8021906983
334O-linked_GlycosylationDVNAAIATIKTKRTI
CCHHHHHHCCCCCEE
19.5228510447
334PhosphorylationDVNAAIATIKTKRTI
CCHHHHHHCCCCCEE
19.5223401153
336SumoylationNAAIATIKTKRTIQF
HHHHHHCCCCCEEEE
43.57-
336AcetylationNAAIATIKTKRTIQF
HHHHHHCCCCCEEEE
43.57134093
336SumoylationNAAIATIKTKRTIQF
HHHHHHCCCCCEEEE
43.57-
336UbiquitinationNAAIATIKTKRTIQF
HHHHHHCCCCCEEEE
43.5720639865
337PhosphorylationAAIATIKTKRTIQFV
HHHHHCCCCCEEEEE
23.1630266825
338MethylationAIATIKTKRTIQFVD
HHHHCCCCCEEEEEE
42.41184699
338UbiquitinationAIATIKTKRTIQFVD
HHHHCCCCCEEEEEE
42.4121906983
340O-linked_GlycosylationATIKTKRTIQFVDWC
HHCCCCCEEEEEEEC
22.2328510447
340PhosphorylationATIKTKRTIQFVDWC
HHCCCCCEEEEEEEC
22.2328857561
347GlutathionylationTIQFVDWCPTGFKVG
EEEEEEECCCCEEEE
1.5522555962
349PhosphorylationQFVDWCPTGFKVGIN
EEEEECCCCEEEEEE
52.7121712546
352AcetylationDWCPTGFKVGINYQP
EECCCCEEEEEECCC
40.68129743
352SumoylationDWCPTGFKVGINYQP
EECCCCEEEEEECCC
40.68-
352UbiquitinationDWCPTGFKVGINYQP
EECCCCEEEEEECCC
40.68-
357PhosphorylationGFKVGINYQPPTVVP
CEEEEEECCCCEECC
22.0727273156
361PhosphorylationGINYQPPTVVPGGDL
EEECCCCEECCCCCH
40.6028152594
370SumoylationVPGGDLAKVQRAVCM
CCCCCHHHHHHHHHH
46.31-
370AcetylationVPGGDLAKVQRAVCM
CCCCCHHHHHHHHHH
46.31184703
370SumoylationVPGGDLAKVQRAVCM
CCCCCHHHHHHHHHH
46.31-
370UbiquitinationVPGGDLAKVQRAVCM
CCCCCHHHHHHHHHH
46.3121906983
376GlutathionylationAKVQRAVCMLSNTTA
HHHHHHHHHHCCCHH
1.9022555962
377SulfoxidationKVQRAVCMLSNTTAV
HHHHHHHHHCCCHHH
3.5528465586
379PhosphorylationQRAVCMLSNTTAVAE
HHHHHHHCCCHHHHH
12.7821712546
381O-linked_GlycosylationAVCMLSNTTAVAEAW
HHHHHCCCHHHHHHH
16.8628510447
382O-linked_GlycosylationVCMLSNTTAVAEAWA
HHHHCCCHHHHHHHH
24.3228510447
394SumoylationAWARLDHKFDLMYAK
HHHHCCCCCCHHHEE
39.99-
394AcetylationAWARLDHKFDLMYAK
HHHHCCCCCCHHHEE
39.99134089
394SumoylationAWARLDHKFDLMYAK
HHHHCCCCCCHHHEE
39.99-
394UbiquitinationAWARLDHKFDLMYAK
HHHHCCCCCCHHHEE
39.9921890473
399PhosphorylationDHKFDLMYAKRAFVH
CCCCCHHHEEEHHHH
19.1028674151
401SumoylationKFDLMYAKRAFVHWY
CCCHHHEEEHHHHHH
27.11-
401AcetylationKFDLMYAKRAFVHWY
CCCHHHEEEHHHHHH
27.11129751
401SumoylationKFDLMYAKRAFVHWY
CCCHHHEEEHHHHHH
27.11-
401UbiquitinationKFDLMYAKRAFVHWY
CCCHHHEEEHHHHHH
27.1121890473
408PhosphorylationKRAFVHWYVGEGMEE
EEHHHHHHCCCCCCC
5.4528796482
419O-linked_GlycosylationGMEEGEFSEAREDMA
CCCCCCHHHHHHHHH
26.5028510447
419PhosphorylationGMEEGEFSEAREDMA
CCCCCCHHHHHHHHH
26.5028270605
425SulfoxidationFSEAREDMAALEKDY
HHHHHHHHHHHHHHH
1.6930846556
430UbiquitinationEDMAALEKDYEEVGA
HHHHHHHHHHHHHCC
67.4721906983
432PhosphorylationMAALEKDYEEVGADS
HHHHHHHHHHHCCCC
25.6728176443
439PhosphorylationYEEVGADSADGEDEG
HHHHCCCCCCCCCCC
27.9425159151
449NitrationGEDEGEEY-------
CCCCCCCC-------
21.39-
449PhosphorylationGEDEGEEY-------
CCCCCCCC-------
21.3928176443

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
158SPhosphorylationKinasePRKCAP17252
GPS
165SPhosphorylationKinasePRKCAP17252
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
40KAcetylation

24906155
40KMethylation

24906155

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TBA1C_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TBB6_HUMANTUBB6physical
22939629
TBB3_HUMANTUBB3physical
22939629
TBA4A_HUMANTUBA4Aphysical
22939629
VATB2_HUMANATP6V1B2physical
22939629
G3P_HUMANGAPDHphysical
22863883
TBA4A_HUMANTUBA4Aphysical
22863883
TBB4B_HUMANTUBB4Bphysical
22863883
TBB5_HUMANTUBBphysical
22863883
RM02_HUMANMRPL2physical
26344197
TBB5_HUMANTUBBphysical
26344197
AL3A2_HUMANALDH3A2physical
26496610
ADT2_HUMANSLC25A5physical
26496610
AT1A1_HUMANATP1A1physical
26496610
AT2A2_HUMANATP2A2physical
26496610
AT2B1_HUMANATP2B1physical
26496610
ATPA_HUMANATP5A1physical
26496610
ATPB_HUMANATP5Bphysical
26496610
AUP1_HUMANAUP1physical
26496610
BASI_HUMANBSGphysical
26496610
PYR1_HUMANCADphysical
26496610
TCPZ_HUMANCCT6Aphysical
26496610
CPSM_HUMANCPS1physical
26496610
EF1A1_HUMANEEF1A1physical
26496610
GCDH_HUMANGCDHphysical
26496610
DNJA1_HUMANDNAJA1physical
26496610
HSPB1_HUMANHSPB1physical
26496610
HS90B_HUMANHSP90AB1physical
26496610
CH60_HUMANHSPD1physical
26496610
PDE3A_HUMANPDE3Aphysical
26496610
MPCP_HUMANSLC25A3physical
26496610
PRS8_HUMANPSMC5physical
26496610
RCN1_HUMANRCN1physical
26496610
RCN2_HUMANRCN2physical
26496610
RNF5_HUMANRNF5physical
26496610
RPN1_HUMANRPN1physical
26496610
AAAT_HUMANSLC1A5physical
26496610
SSRD_HUMANSSR4physical
26496610
TCPA_HUMANTCP1physical
26496610
TCPG_HUMANCCT3physical
26496610
FXR1_HUMANFXR1physical
26496610
LAT1_HUMANSLC7A5physical
26496610
ATPK_HUMANATP5J2physical
26496610
LGAT1_HUMANLPGAT1physical
26496610
KIF14_HUMANKIF14physical
26496610
TXND9_HUMANTXNDC9physical
26496610
DNJA2_HUMANDNAJA2physical
26496610
TBA1B_HUMANTUBA1Bphysical
26496610
TBB3_HUMANTUBB3physical
26496610
TBB4B_HUMANTUBB4Bphysical
26496610
HAX1_HUMANHAX1physical
26496610
TCPH_HUMANCCT7physical
26496610
TCPD_HUMANCCT4physical
26496610
TCPB_HUMANCCT2physical
26496610
ATP5L_HUMANATP5Lphysical
26496610
TCPQ_HUMANCCT8physical
26496610
AFG32_HUMANAFG3L2physical
26496610
SC61B_HUMANSEC61Bphysical
26496610
STIP1_HUMANSTIP1physical
26496610
GCN1_HUMANGCN1L1physical
26496610
TCPE_HUMANCCT5physical
26496610
TRI32_HUMANTRIM32physical
26496610
FAF2_HUMANFAF2physical
26496610
EMAL2_HUMANEML2physical
26496610
ATX10_HUMANATXN10physical
26496610
SERA_HUMANPHGDHphysical
26496610
PTHB1_HUMANBBS9physical
26496610
PKN3_HUMANPKN3physical
26496610
ZC21A_HUMANZC2HC1Aphysical
26496610
ATD3A_HUMANATAD3Aphysical
26496610
MA7D1_HUMANMAP7D1physical
26496610
ZNFX1_HUMANZNFX1physical
26496610
ESYT2_HUMANESYT2physical
26496610
SRPRB_HUMANSRPRBphysical
26496610
AHNK_HUMANAHNAKphysical
26496610
YIPF5_HUMANYIPF5physical
26496610
TBB6_HUMANTUBB6physical
26496610
USMG5_HUMANUSMG5physical
26496610
TM209_HUMANTMEM209physical
26496610
NEK9_HUMANNEK9physical
26496610
RRFM_HUMANMRRFphysical
26496610
TIM50_HUMANTIMM50physical
26496610
PGAM5_HUMANPGAM5physical
26496610
TBB5_HUMANTUBBphysical
26496610
T11L2_HUMANTCP11L2physical
26496610
T11L2_HUMANTCP11L2physical
28514442
TBA4A_HUMANTUBA4Aphysical
28514442
TTC5_HUMANTTC5physical
28514442
TCPW_HUMANCCT6Bphysical
28514442

Drug and Disease Associations
Kegg Disease
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TBA1C_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-112, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-432 AND SER-439, ANDMASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-439, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48 AND SER-439, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48 AND SER-439, AND MASSSPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-41; SER-48; THR-51;THR-334 AND SER-439, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48 AND SER-439, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-357, AND MASSSPECTROMETRY.

TOP